ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Retained Earnings
Cumulative profits kept in the business rather than paid out as dividends.
Retained Earnings history
Currency unavailable · from the balance sheet
No Retained Earnings data reported for this period type.
Retained Earnings vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $12.13M USD | — | — | 4.1% | |
| Mar 2026 | -$260.91M USD | -23.1% | — | 139.5% | |
| Mar 2026 | -€479.39M EUR | -1.7% | — | 483.6% | |
| Mar 2026 | -$541.55M USD | -17.0% | — | 220.7% | |
| Mar 2026 | -$547.72M USD | -44.9% | — | 123.6% | |
| Mar 2026 | -$577.53M USD | -214.9% | — | 501.7% | |
| Mar 2026 | -$862.54M USD | -16.2% | — | 352.6% | |
| Mar 2026 | -$937.48M USD | -26.8% | — | 318.1% | |
| Mar 2026 | -$1.35B USD | -15.7% | — | 231.7% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -20.0% | — | 231.7% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.